AzTrials
AzTrials

Musculoskeletal HealthNCT06801210

The Weight of Victory: Exploring Short- and Long-term Health Outcomes in Former Male & Female Elite Athletes From Weight-sensitive Sports

An observational study of Musculoskeletal Health and Fertility, run by Norwegian School of Sport Sciences at 1 site in Norway.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The health of former elite athletes has been identified as a critical research gap where there is limited knowledge about both short- and long-term consequences after ending their careers. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Musculoskeletal Health, Fertility, Mental Health
How many people
1,500 participants
Where
1 siteNorway
Study dates
5 Jun 2025to 31 Aug 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Former male and female Norwegian elite athletes and a age matched controls from the general population

Who may be able to join

  • Represented the national team at senior and/or junior level, (Non-organized sports) competed at national and/or international level. , >1 year since retirement , >18 years old,and a proficient level of Norwegian reading and writing skills

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Norway1 site
  • Norwegian School of Sport Sciences

    Oslo, 0862

Other trials in Norway

About this study

Official title: The Weight of Victory: Exploring Short- and Long-term Health Outcomes in Former Male & Female Elite Atheltes From Weight-sensitive Sports

The health of former elite athletes has been identified as a critical research gap where there is limited knowledge about both short- and long-term consequences after ending their careers. The transition phase from an active elite career to everyday life has been shown to be particularly problematic, yet this issue has been little studied among former Norwegian elite athletes. Furthermore, questions remain regarding the health of athletes from weight-sensitive sports, such as weight-class, aesthetic, and certain endurance sports. These athletes face specific challenges related to maintaining a certain physique and frequent changes in body weight during their active careers. This group has been shown to be vulnerable to a range of problematic health outcomes related to low energy availability, and little is known about the long-term effects of a career involving this.

Therefore, the overall purpose of the project is to map the mental and physical health of former elite athletes. At the same time, there will be a particular focus on the differences between weight-sensitive and less weight-sensitive sports, different types of sports, gender, as well as previous dieting and eating behaviors.

Read the detailed description

The project will be a quantitative cross-sectional study that includes former elite athletes from both weight-sensitive and less weight-sensitive sports, as well as a sample from the general population for comparison. Information will be collected via an electronic questionnaire that surveys a range of physical and mental health variables among the participants. In addition, behavioral variables related to impulse control, eating and dieting patterns, and weight regulation will be assessed.

Furthermore, the project is expected to contribute new knowledge by identifying health challenges and the explanatory variables for these challenges among former elite athletes. Thus, the project can inform the development of targeted preventive measures, interventions, and policy changes that can improve health and quality of life both during and after athletes' careers and be of significant importance for future athletes.

Keywords
Elite athletes, Mental health, Somatic health, Disordered eating, Musculoskeletal health, Quality of life, Anxiety and depression, Behavioral, Reproductive health, Fertility, Harassment, Body acceptance, Personality traits, Weight regulation
Medical subject headings
Psychological Well-Being, Anxiety Disorders, Depression, Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06801210
Study groupRoleWhat they receive
Former elite athletes from weight-sensitive sportsFormer elite athletes from weight-sensitive sports. Including former elite athletes from weight-class, gravitational, aesthetic, and certain endurance type of sports.
Former elite athletes from less weight-sensitive sportsFormer elite athletes from less weight-sensitive sports. Including team sports (e.g. handball, soccer, basketball)
General populationAn age matched reference group for the groups of former elite athletes. Includes a sample from the general population without a background as an elite athlete.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Symptoms of eating disorders (Eating Disorder Examination Questionnaire, EDE-Q)

    This outcome measure will use the Eating Disorder Examination Questionnaire (EDE-Q) to assess the frequency and severity of eating disorder symptoms. The EDE-Q is a validated self-report questionnaire covering dietary restraint, eating concern, shape concern, and weight concern

    Measured: January 2025 to June 2025

  2. Pain, function, and overall well-being connected to musculoskeletal status (Musculoskeletal Health Questionnaire, MSK-HQ)

    This outcome measure will use the Musculoskeletal Health Questionnaire (MSK-HQ) to assess self-reported musculoskeletal health. The MSK-HQ is a validated instrument covering key domains such as pain, function, and overall well-being in individuals with musculoskeletal conditions. It provides a comprehensive overview of the patient's musculoskeletal status, including symptoms and the impact on daily activities.

    Measured: From January 2025 to June 2025

  3. Menstrual function and history & fertility function and history (The Low Energy Availability in Males Questionnaire, LEAM-Q, Low Energy Availability in Females Questionnaire, LEAF-Q, and The Norwegian Mother, Father and Child Cohort Study, MoBa)

    Items from The validated Low Energy Availability in Females Questionnaire (LEAF-Q) will be included to assess menstrual function (Melin et al., 2014). Items from The Low Energy Availability in Males Questionnaire (LEAM-Q) (Lundy et al., 2022) will be included for assessing reproductive health among the male participants. In addition, questions from The Norwegian Mother, Father and Child Cohort Study (MoBa) will be included to cover fertility status.

    Measured: From January 2025 to June 2025

Secondary outcomes (5)
  1. Symptoms of Psychological Distress (Symptom Checklist-10, SCL-10)

    This outcome measure will use the Symptom Checklist-10 (SCL-10) to assess the frequency and severity of common mental distress symptoms. The SCL-10 is a validated, abbreviated version of the SCL family of instruments (e.g., SCL-25, SCL-90) that covers core areas such as anxiety, depression, and somatic complaints. It provides an overall indication of the level of psychological distress and can be used for both screening and monitoring changes over time.

    Measured: From January 2025 to June 2025

  2. Alchohol and drug use (Alcohol Use Disorders Identification Test - Consumption, AUDIT-C and Drug Use Disorders Identification Test, DUDIT)

    The AUDIT-C assesses alcohol consumption, drinking behaviors, and alcohol-related issues (Babor et al., 2001). The Drug Use Disorders Identification Test (DUDIT) will be included. The DUDIT assesses symptoms of substance abuse, as well as harmful use, and drug dependence.

    Measured: From January 2025 to June 2025

  3. Satisfaction With Life (Satisfaction With Life Scale, SWLS)

    This outcome measure will use the Satisfaction With Life Scale (SWLS) to evaluate individuals' overall assessments of their own life satisfaction. The SWLS is a validated, brief questionnaire comprising five statements that respondents rate based on their level of agreement. It captures the cognitive judgment of one's life quality, providing a reliable indicator of subjective well-being and overall life satisfaction.

    Measured: From January 2025 to June 2025

  4. Cognitive Function (PROMIS® v2.0 Cognitive Function-Short Form 6a)

    This outcome measure will utilize the PROMIS® v2.0 Cognitive Function-Short Form 6a to assess individuals' self-reported cognitive abilities. The PROMIS Cognitive Function-Short Form 6a is a validated, brief questionnaire designed to evaluate various aspects of cognitive performance, including memory, concentration, and mental clarity

    Measured: From January 2025 to June 2025

  5. Body Appreciation and Muscle Dysmorphic Disorder Symptoms (Body Appreciation Scale-2, BAS-2, and the Muscle Dysmorphic Disorder Inventory, MDDI)

    The Body appreciation scale-2 (BAS-2) is a 10-item measure of an individual's acceptance, opinions and respect of their own body, The questionnaire is validated. Body satisfaction will be measured with the inclusion of the Muscle Dysmorphic Disorder Inventory (MDDI). The MDDI is a 13-item self-report measure which have three sub-scales assessing clinical features associated with muscle dysmorphia (MD), including drive for size, functional impairment, and appearance intolerance

    Measured: From January 2025 to June 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2025
  2. Study start5 Jun 2025
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion31 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
1,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06801210
Sponsor's protocol ID
841008
Status last verified
Aug 2026
First submitted
16 Jan 2025
Last updated
28 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Musculoskeletal Health and Fertility, run by Norwegian School of Sport Sciences at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 28 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Symptoms of eating disorders (Eating Disorder Examination Questionnaire, EDE-Q) (time frame: January 2025 to June 2025). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in